Search research articles
Contact Us
Filters
Showing results (341-350 of 369) with videos related to
Page
of 37
Sort By:
Acta Neuropathologica
|
June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytoma
Maja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica Communications
|
October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Annekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Neuro-Oncology
|
June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages
Abigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica
|
November 26, 2025
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas
Felix E Hinz, Dennis Friedel, Franziska M Ippen, et al.
Acta Neuropathologica
|
March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
Henri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica
|
February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
Felix Hinz, Dennis Friedel, Andrey Korshunov, et al.
Neuro-Oncology
|
December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies
Aniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Cancer Discovery
|
April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas
Tuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Acta Neuropathologica
|
September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
Annika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Epilepsia
|
February 24, 2024
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 cases
Richard Drexler, Franz L Ricklefs, Sharona Ben-Haim, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 369) with videos related to
Sort By:
Page
of 37
Acta Neuropathologica
|
June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytoma
Maja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica Communications
|
October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Annekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Neuro-Oncology
|
June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages
Abigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica
|
November 26, 2025
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas
Felix E Hinz, Dennis Friedel, Franziska M Ippen, et al.
Acta Neuropathologica
|
March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
Henri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica
|
February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
Felix Hinz, Dennis Friedel, Andrey Korshunov, et al.
Neuro-Oncology
|
December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies
Aniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Cancer Discovery
|
April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas
Tuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Acta Neuropathologica
|
September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
Annika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Epilepsia
|
February 24, 2024
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 cases
Richard Drexler, Franz L Ricklefs, Sharona Ben-Haim, et al.
Page
of 37